LNTH

#1119
Lantheus Holdings, Inc
74.9100
-1.06%
Secteur:
Base:
Devise de Profit:
Range quotidien
74.9100
74.9100
Range Annuel
50.1550
80.9100
Changement quotidien
-1.06%
Changement Mensuel
+9.98%
Evolution sur 6 mois
+33.62%
Changement Annuel
+33.62%
Clôture Précédente
75.7150
Open
74.9100
Bid
Ask
Low
74.9100
High
74.9100
Volume
194
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Lantheus Holdings Inc

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Nouvelles